X
Email:
sales@ruixibiotech.com

Nintedanib and Dexamethasone@Liposomal CY5.5,100-150nm

Liposome loaded with Nintedanib and Dexamethasone modified CY5.5

Catalog # Pkg Size Price(USD) Quantity Buy this product
R-Mcs-517 50mg 1659.00
- +
+ Add to cart

Product description

Nintedanib and Dexamethasone@Liposomal CY5.5,100-150nm/Liposome@with Nintedanib and Dexamethasone modified CY5.5 is a multifunctional targeted nano delivery system that achieves synergistic anti fibrotic and anti-inflammatory effects through liposome encapsulated dual drugs, and uses CY5.5 near-infrared fluorescence labeling to achieve real-time visualization tracking of in vivo distribution. It is mainly used for the study of acute exacerbation of pulmonary fibrosis (AE-IPF) or tumor related fibrosis microenvironment.

Nintedanib and Dexamethasone@Liposomal CY5.5,100-150nm

Appearance Freeze-dried powder
Size 100-150nm
Solubility N/A
Drug loading 4.2%(Nintedanib); 0.85%(Dexamethasone)
Encapsulation efficiency 91.3%(Nintedanib); 93.3%(Dexamethasone)
Storage -20℃, protected from light and moisture
Transportation 4-25℃ temperature for up to 1-3 weeks
Stability 6 months
Document

Related Product